Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP):: importance of PLTP in preβ-HDL generation

被引:28
作者
Jaari, S
van Dijk, KW
Olkkonen, VM
van der Zee, A
Metso, J
Havekes, L
Jauhiainen, M
Ehnholm, C
机构
[1] Natl Publ Hlth Inst, Dept Biochem, SF-00300 Helsinki, Finland
[2] TNO Prevent & Hlth, Gaubius Lab, Leiden, Netherlands
来源
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY | 2001年 / 128卷 / 04期
关键词
adenovirus vector; apolipoprotein; HDL metabolism; lipoprotein; PLTP; reverse cholesterol transport;
D O I
10.1016/S1096-4959(01)00297-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The plasma phospholipid transfer protein (PLTP) plays an important role in the regulation of plasma high density lipoprotein (HDL) levels and governs the distribution of HDL sub-populations. In the present study, adenovirus mediated overexpression of human PLTP in mice was employed to investigate the distribution of PLTP in serum and its effect on plasma lipoproteins. Gel filtration experiments showed that the distributions of PLTP activity and mass in serum are different, suggesting that human PLTP circulated in mouse plasma as two distinct forms, one with high and the other with low specific activity. Our study further demonstrates that overexpression of PLTP leads to depletion of HDL and that, as PLTP activity declines, replenishment of the HDL fraction occurs. During this process, the lipoprotein profile displays transient particle populations, including apoA-IV and apoE-rich particles in the LDL size range and small particles containing apoA-II only. The possible role of these particles in HDL reassembly is discussed. The increased PLTP activity enhanced the ability of mouse sera to produce prep-HDL. The present results provide novel evidence that PLTP is an important regulator of HDL metabolism and plays a central role in the reverse cholesterol transport (RCT) process. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:781 / 792
页数:12
相关论文
共 44 条
[11]   Plasma phospholipid transfer protein - Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL [J].
Foger, B ;
SantamarinaFojo, S ;
Shamburek, RD ;
Parrot, CL ;
Talley, GD ;
Brewer, HB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (43) :27393-27400
[12]   Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein [J].
Hailman, E ;
Albers, JJ ;
Wolfbauer, G ;
Tu, AY ;
Wright, SD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12172-12178
[13]   CHOLESTEROL EFFLUX, CHOLESTEROL ESTERIFICATION, AND CHOLESTERYL ESTER TRANSFER BY LPA-I AND LPA-I/A-II IN NATIVE PLASMA [J].
HUANG, YD ;
VONECKARDSTEIN, A ;
WU, SL ;
ASSMANN, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1412-1418
[14]   Phospholipid transfer protein in lipid metabolism [J].
Huuskonen, J ;
Ehnholm, C .
CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (03) :285-289
[15]   Quantification of human plasma phospholipid transfer protein (PLTP):: relationship between PLTP mass and phospholipid transfer activity [J].
Huuskonen, J ;
Ekström, M ;
Tahvanainen, E ;
Vainio, A ;
Metso, J ;
Pussinen, P ;
Ehnholm, C ;
Olkkonen, VM ;
Jauhiainen, M .
ATHEROSCLEROSIS, 2000, 151 (02) :451-461
[16]  
IKEWAKI K, 1995, THROMB VASC BIOL, V15, P306
[17]  
JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032
[18]  
JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032
[19]   Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels [J].
Jiang, XC ;
Bruce, C ;
Mar, J ;
Lin, M ;
Ji, Y ;
Francone, OL ;
Tall, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :907-914
[20]   Increased pre beta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes [J].
Jiang, XC ;
Francone, OL ;
Bruce, C ;
Milne, R ;
Mar, J ;
Walsh, A ;
Breslow, JL ;
Tall, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (10) :2373-2380